Your browser doesn't support javascript.
loading
Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich syndrome): Frequency, clinical implication, and prognosis.
Abisror, Noémie; Mekinian, Arsène; Dechartres, Agnès; Groh, Matthieu; Berezne, Alice; Noel, Nicolas; Morati, Chafika; Haroche, Julien; Hunault-Berger, Mathilde; Agard, Christian; Ackermann, Felix; Geffray, Loïk; Jeandel, Pierre-Yves; Trouillier, Sébastien; Quemeneur, Thomas; Dufour, Jean-François; Lamaury, Isabelle; Lhote, François; Lefèvre, Guillaume; Fain, Olivier; Kahn, Jean Emmanuel.
Affiliation
  • Abisror N; AP-HP, Hôpital Saint Antoine, Service de Médecine Interne, Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biotherapie (DHU i2B) (DHU i2B), Faculté de Médecine Sorbonne Université, Paris, France. Electronic address: noemie.abisror@gmail.com.
  • Mekinian A; Sorbonne Université, Inserm U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Département Biostatistique, Santé Publique, Information Médicale-Hôpital Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • Dechartres A; Service de Médecine Interne, Université Versailles Saint-Quentin-en-Yvelines, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France.
  • Groh M; Service de Médecine Interne, Université Versailles Saint-Quentin-en-Yvelines, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France.
  • Berezne A; Service de Médecine Interne, CH Annecy Genevois, Annecy, France.
  • Noel N; Department of Internal Medicine, Assistance-Publique Hôpitaux de Paris Paris XI University, Hôpital Bicêtre Le Kremlin-Bicêtre, France.
  • Morati C; Service de Médecine Interne, CH Annecy Genevois, Annecy, France.
  • Haroche J; Department of Internal Medicine, French Reference Centre for Rare Autoimmune Systemic Diseases, e3m Institute, Assistance-Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, and Paris VI University (UPMC), Sorbonne Universités, Paris, France.
  • Hunault-Berger M; Maladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
  • Agard C; Service de Médecine Interne, CHU Hôtel-Dieu, Nantes, France.
  • Ackermann F; Service de Médecine Interne, Université Versailles Saint-Quentin-en-Yvelines, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France.
  • Geffray L; Service de médecine interne, Centre Hospitalier, Lisieux, France.
  • Jeandel PY; Service de Médecine Interne, Centre Hospitalier Universitaire de Nice, Nice, France.
  • Trouillier S; Service de Médecine Interne, Centre Hospitalier d'Aurillac, Aurillac, France.
  • Quemeneur T; Département de Néphrologie et Département de Médecine Interne, Centre Hospitalier de Valenciennes, Valenciennes, France.
  • Dufour JF; Service de Médecine Interne et Post-Urgence, Centre Hospitalier de Bourg-en-Bresse, Bourg-en-Bresse, France.
  • Lamaury I; Inserm-CIC 1424 et Service de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, France.
  • Lhote F; Service de Médecine Interne, Hôpital de Saint-Denis, Saint-Denis, France.
  • Lefèvre G; U995, LIRIC-Lille Inflammation Research International Center; INSERM, U995; Département de Médecine Interne et Immunologie Clinique, Centre National de Référence Maladies Systémiques et Auto-immunes Rares (Sclérodermie Systémique), Centre de Référence des Syndromes Hyperéosinophiliques (CEREO); and
  • Fain O; AP-HP, Hôpital Saint Antoine, Service de Médecine Interne, Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biotherapie (DHU i2B) (DHU i2B), Faculté de Médecine Sorbonne Université, Paris, France.
  • Kahn JE; Service de Médecine Interne, Université Versailles Saint-Quentin-en-Yvelines, Centre de Référence des Syndromes Hyperéosinophiliques (CEREO), Hôpital Foch, Suresnes, France.
J Am Acad Dermatol ; 88(5): e243-e250, 2023 05.
Article in En | MEDLINE | ID: mdl-30738125
BACKGROUND: Episodic angioedema with eosinophilia (EAE) (Gleich syndrome) is a rare disorder consisting of recurrent episodes of angioedema, hypereosinophilia, and frequent elevated serum IgM level. METHODS: We conducted a retrospective multicenter nationwide study regarding the clinical spectrum and therapeutic management of patients with EAE in France. RESULTS: A total of 30 patients with a median age at diagnosis of 41 years (range, 5-84) were included. The median duration of each crisis was 5.5 days (range, 1-90), with swelling affecting mainly the face and the upper limbs. Total serum IgM levels were increased in 20 patients (67%). Abnormal T-cell immunophenotypes were detected in 12 patients (40%), of whom 5 (17%) showed evidence of clonal T-cell receptor gamma locus gene (TRG) rearrangement. The median duration of follow-up was 53 months (range, 31-99). The presence of an abnormal T-cell population was the sole factor associated with a shorter time to flare (hazard ratio, 4.15; 95% confidence interval, 1.18-14.66; P = .02). At last follow-up, 3 patients (10%) were able to have all treatments withdrawn and 11 (37%) were in clinical and biologic remission with less than 10 mg of prednisone daily. CONCLUSION: EAE is a heterogeneous condition that encompasses several disease forms. Although patients usually respond well to glucocorticoids, those with evidence of abnormal T-cell phenotype have a shorter time to flare.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eosinophilia / Angioedema Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2023 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eosinophilia / Angioedema Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Am Acad Dermatol Year: 2023 Document type: Article Country of publication: Estados Unidos